Kinea Bio
Operator of a biotechnology company intended to accelerate the development of next-generation AAV-based gene therapies to treat neuromuscular diseases. The company offers novel targeting and gene regu...
Valuation
$0
Share Price
N/A
Total Raised
$1.6M
Last Round
N/A